OBJECTIVE: Existing data regarding the association of chorioamnionitis and child neurodevelopmental outcomes are limited by a focus on early preterm populations and short duration of follow-up. Our objective was to assess long -term child neurodevelopmental outcomes after exposure to chorioamnionitis during the late preterm and term periods. STUDY DESIGN: This is a secondary analysis of a multicenter randomized controlled trial of treatment for subclinical hypothyroidism or hypothyroxinemia during pregnancy. Trained research personnel abstracted all records and performed child evaluations. All women delivering singleton live births at or after 34 weeks' gestation and whose neonates had at least 3 years of neurodevelopmental data were included. Chorioamnionitis was diagnosed clinically based on attending confirmation of maternal fever (!37.8 C) and no other defined infection. The primary outcome was intelligence quotient (IQ) score at 5 years of age (Wechsler Preschool and Primary Scale of Intelligence-III). Secondary outcomes included the Bayley Scales of Infant Development (12 and 24 months), the Differential Ability Scales-II for IQ (36 months), the Conners' Rating Scales for child attention (48 months), and the Child Behavioral Checklist for behavioral and social competency (36 and 60 months). Offspring whose mothers had chorioamnionitis were compared to those whose mothers did not using univariable and multivariable analyses. RESULTS: A total of 1203 women were enrolled in the trial, and 1117 (93%) mother-child pairs were included in this secondary analysis. The majority (93.2%) delivered after 37 weeks (mean GA 38.9 AE 1.5 weeks). The 5.1% (N¼57) of women with chorioamnionitis were younger and more likely to deliver post-term, and be of Hispanic ethnicity, primiparous, and delivered by cesarean. The mean (S.D.) IQ for 5 year old children who were exposed to chorioamnionitis did not differ from those not exposed (95 AE 13 vs. 95 AE 15, p¼0.88), a finding which remained non-significant after multivariable adjustment for potential confounders (b 1.6, 95% CI -1.9 to 5.0). Similarly, no secondary outcomes differed at any age based on fetal exposure to chorioamnionitis. CONCLUSION: Among children who delivered in the late preterm or term period, a clinical diagnosis of chorioamnionitis was not associated with adverse neurodevelopmental outcomes in early childhood.
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